IP Law Daily, PATENT—D.N.J.: Drugmaker loses cancer drug patent term extensions after missing statutory filing deadline by one day, (Oct 28, 2026)Law Firms Mentioned:McCarter & English, LLPOrganizations Mentioned:Taiho Pharmaceutical Co., Ltd.By Ravindra Kumar Singh, B.L.The drugmaker’s attempt to rely on a corrected FDA approval letter failed because the original approval triggered the statutory 60-day filing period, leaving its patent term extension applications one day late.A pharmaceutical company lost its ...